AvalehtME • NASDAQ
add
23andMe Holding Co.
3,11 $
Pärast sulgemist:(3,54%)+0,11
3,22 $
Suletud: 22. nov, 18:26:25 GMT −5 · USD · NASDAQ · Välistus
Viimane sulgemishind
3,23 $
Tänane vahemik
2,99 $ - 3,21 $
Aasta vahemik
2,66 $ - 20,20 $
Turuväärtus
74,94 mln USD
Keskmine maht
404,88 tuh
P/E suhe
-
Dividendimäär
-
Põhibörs
NASDAQ
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
(USD) | sept 2024info | Y/Y muutus |
---|---|---|
Käive | 44,07 mln | −11,86% |
Põhitegevusega seonduv kulu | 81,33 mln | −17,18% |
Puhastulu | −59,10 mln | 21,48% |
Puhaskasumimarginaal | −134,11 | 10,91% |
Puhaskasum aktsia kohta | — | — |
EBITDA | −54,96 mln | 21,06% |
Tõhus maksumäär | 0,07% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
(USD) | sept 2024info | Y/Y muutus |
---|---|---|
Sularaha ja lühiajalised investeeringud | 126,60 mln | −50,62% |
Kogu vara | 318,94 mln | −60,19% |
Kõik kohustused | 217,01 mln | 23,31% |
Kogu omakapital | 101,93 mln | — |
Emiteeritud aktsiate arv | 26,12 mln | — |
Hinna ja väärtuse suhe P/B | 0,82 | — |
Varade tasuvus | −42,89% | — |
Kapitali tasuvus | −75,30% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
(USD) | sept 2024info | Y/Y muutus |
---|---|---|
Puhastulu | −59,10 mln | 21,48% |
Põhitegevuse rahakäive | −40,93 mln | 28,34% |
Investeeringute raha | −2,70 mln | 2,63% |
Finantseerimise raha | 260,00 tuh | −83,68% |
Raha ja raha ekvivalentide muutus | −43,37 mln | 25,18% |
Tasuta rahavoog | −12,82 mln | 59,90% |
Teave
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Tegevjuht
Asutatud
apr 2006
Veebisait
Töötajate arv
571